What is Survodutide used for?
Survodutide is most commonly used for users plateaued on GLP-1-only drugs; people targeting >15% body weight loss; phase 2 / 3 trial-followers wanting cutting-edge. A weight-loss drug built for a stronger fat-burn signal than GLP-1-only options. A dual agonist (GLP-1 + glucagon) from Boehringer Ingelheim / Zealand Pharma, where glucagon activation boosts metabolic rate. Human evidence for Survodutide is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use Survodutide for
- Users plateaued on GLP-1-only drugs
- People targeting >15% body weight loss
- Phase 2 / 3 trial-followers wanting cutting-edge
References
- Survodutide for treatment of obesity, Phase 2 trial — le Roux CW et al., Lancet Diabetes Endocrinol, 2024
- A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis — Sanyal et al., N Engl J Med, 2024
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Survodutide
Last updated 2026-06-15.